These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 4904497)
1. Cofactor inhibition of thymidylate synthetase. Tetrahydrofolic acid analogs. Mertes MP; Ai Jeng Lin J Med Chem; 1970 Jan; 13(1):77-82. PubMed ID: 4904497 [No Abstract] [Full Text] [Related]
2. Cofactor inhibitors of thymidylate synthetase. Piperidine and tetrahydroquinoline analogs of tetrahydrofolic acid. Mertes MP; Lin AJ J Med Chem; 1970 Mar; 13(2):276-9. PubMed ID: 5418501 [No Abstract] [Full Text] [Related]
3. The effects of halothane on bacterial division rate. Wardley-Smith B; Nunn JF Br J Anaesth; 1970 Jan; 42(1):89. PubMed ID: 4906517 [No Abstract] [Full Text] [Related]
4. [Effect of 4-(2,4-dichlorophenoxy) butyric acid on Bacillus and other gram-positive and gram-negative bacteria cultures]. Román M; González C; Rodríguez D Zentralbl Bakteriol Parasitenkd Infektionskr Hyg; 1970; 124(2):119-28. PubMed ID: 4918691 [No Abstract] [Full Text] [Related]
5. Inhibition of thymidylate synthetase by 5-formyl- and 5-hydroxymethyl-2'-deoxyuridylate. Santi DV; Sakai TT Biochem Biophys Res Commun; 1971 Mar; 42(5):813-7. PubMed ID: 4929928 [No Abstract] [Full Text] [Related]
6. Inhibition of peptide chain initiation in Escherichia coli by hydroxylamine. Reaction of hydroxylamine with folate coenzymes. Nixon PF; Bertino JR Biochemistry; 1970 Dec; 9(25):4833-8. PubMed ID: 4921069 [No Abstract] [Full Text] [Related]
8. Antibacterial properties of quindoxin: a new growth-promoting agent. Hennessey TD; Edwards JR Vet Rec; 1972 Feb; 90(7):187-91. PubMed ID: 4553051 [No Abstract] [Full Text] [Related]
9. Synthesis of substituted [1]benzothieno[2,3-b]pyrazines and their ability to antagonize KCl induced contractions. Guerrera F; Salerno L; Sarvà MC; Siracusa MA; Rescifina A; Scalia R; Bianchi A Farmaco; 1994; 49(7-8):467-73. PubMed ID: 7945711 [TBL] [Abstract][Full Text] [Related]
10. Studies relating to the mode of action of methotrexate. 3. Inhibition of thymidylate synthetase in tissue culture cells and in cell-free systems. Borsa J; Whitmore GF Mol Pharmacol; 1969 Jul; 5(4):318-32. PubMed ID: 4896040 [No Abstract] [Full Text] [Related]
11. Synthesis, antimalarial activity, and molecular modeling of new pyrrolo[1,2-a]quinoxalines, bispyrrolo[1,2-a]quinoxalines, bispyrido[3,2-e]pyrrolo[1,2-a]pyrazines, and bispyrrolo[1,2-a]thieno[3,2-e]pyrazines. Guillon J; Grellier P; Labaied M; Sonnet P; Léger JM; Déprez-Poulain R; Forfar-Bares I; Dallemagne P; Lemaître N; Péhourcq F; Rochette J; Sergheraert C; Jarry C J Med Chem; 2004 Apr; 47(8):1997-2009. PubMed ID: 15055999 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of thymidylate synthetase by some analogs of tetrahydrofolic acid. Slavik K; Zakrzewski SF Mol Pharmacol; 1967 Jul; 3(4):370-7. PubMed ID: 6033635 [No Abstract] [Full Text] [Related]
13. Studies on models for tetrahydrofolic acid. 3. Hydrolytic interconversions of the tetrahydroquinoxaline analogs at the formate level of oxidation. Benkovic SJ; Bullard WP; Benkovic PA J Am Chem Soc; 1972 Oct; 94(21):7542-9. PubMed ID: 5072867 [No Abstract] [Full Text] [Related]
14. Antibacterial synergism: a proposal for chemotherapeutic potentiation between trimethoprim and sulfamethoxazole. Poe M Science; 1976 Oct; 194(4264):533-5. PubMed ID: 788154 [TBL] [Abstract][Full Text] [Related]
15. Use of 10-propargyl-5,8-dideazafolate and directed mutagenesis to probe the catalytic mechanism of thymidylate synthase. Spencer HT; Villafranca JE; Appleman JR Adv Exp Med Biol; 1993; 338():575-8. PubMed ID: 8304183 [No Abstract] [Full Text] [Related]
16. Analogs of tetrahydrofolic acid XX. Effects of modification of the bridge between the pyrimidyl and phenyl moieties of 2-amino-5-(3-anilinopropyl)-6-methyl-4-pyrimidinol on inhibition of dihydrofolic reductase and thymidylate synthetase II. Baker BR; Ho BT J Pharm Sci; 1965 Aug; 54(8):1187-90. PubMed ID: 5882225 [No Abstract] [Full Text] [Related]
17. Analogs of tetrahydrofolic acid XXIV. Further observations on the mode of pyrimidyl binding to dihydrofolic reductase and thymidylate synthetase by the 2-amino-5-(3-anilinopropyl)-6-methyl-4-pyrimidinol type of inhibitor. Baker BR; Santi DV J Pharm Sci; 1965 Sep; 54(9):1252-7. PubMed ID: 5881214 [No Abstract] [Full Text] [Related]
18. Synthesis and biological evaluation of 2,3-diarylpyrazines and quinoxalines as selective COX-2 inhibitors. Singh SK; Saibaba V; Ravikumar V; Rudrawar SV; Daga P; Rao CS; Akhila V; Hegde P; Rao YK Bioorg Med Chem; 2004 Apr; 12(8):1881-93. PubMed ID: 15051057 [TBL] [Abstract][Full Text] [Related]
19. Tetrahydropyrrolo[1,2-a]quinoxalines and tetrahydropyrrolo[1,2-a]pyrido[3,2-a]pyrazines: vascular smooth muscle relaxants and antihypertensive agents. Abou-Gharbia M; Freed ME; McCaully RJ; Silver PJ; Wendt RL J Med Chem; 1984 Dec; 27(12):1743-6. PubMed ID: 6502606 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory. Zhang F; Wen Q; Wang SF; Shahla Karim B; Yang YS; Liu JJ; Zhang WM; Zhu HL Bioorg Med Chem Lett; 2014 Jan; 24(1):90-5. PubMed ID: 24332628 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]